CUSIP 00974H104COMQ2 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ2 2025
57 funds hold this security · Q2 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blue Water Life Science Advisors, LP | 4.70M | $6.11M | 0 | Held |
| 2 | Oddo Bhf Asset Management Sas | 1.89M | $2.46M | +1.89M | New |
| 3 | Vanguard Group Inc | 1.19M | $1.55M | −194.1K | Reduced |
| 4 | Paragon Associates & Paragon Associates II Joint Venture | 671.0K |
| $872.3K |
| 0 |
| Held |
| 5 | Trium Capital LLP | 605.5K | $787.1K | +605.5K | New |
| 6 | Blackrock, Inc. | 499.5K | $649.4K | −1.11M | Reduced |
| 7 | Geode Capital Management, LLC | 245.7K | $319.4K | −321.3K | Reduced |
| 8 | Peddock Capital Advisors, LLC | 234.7K | $305.1K | 0 | Held |
| 9 | Jane Street Group, LLC | 179.4K | $233.2K | +164.2K | Added |
| 10 | State Street Corp | 177.4K | $230.7K | −316.3K | Reduced |
See every fund holding Akoya Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders